The effects of Apollon downregulation on the in vitro proliferative potential of breast cancer cells were further evaluated using Apo2, which was able to inhibit the protein expression by ∼90% at 72 h after transfection in all cell lines (Figure 1B and D). The gene discussed is TNFRSF10A; the disease is breast carcinoma.